Get complete Patent Opposition Report for Laboratorios Liconsa

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Laboratorios Liconsa

Explore patent oppositions filed by Laboratorios Liconsa against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3453387Dosage Regimen For A S1P Receptor AgonistNOVARTISMar 3, 2021
EP3102187Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release TabletsGALENICUM HEALTH SLDec 23, 2020
EP3103448Pharmaceutical Compositions Comprising An S1P ModulatorNOVARTISApr 3, 2020